{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:23:54Z","timestamp":1778883834628,"version":"3.51.4"},"reference-count":42,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T00:00:00Z","timestamp":1500336000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T00:00:00Z","timestamp":1500336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prenat Diagn"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1002\/pd.5090","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T13:32:39Z","timestamp":1497447159000},"page":"802-807","source":"Crossref","is-referenced-by-count":23,"title":["Expanded conventional first trimester screening"],"prefix":"10.1002","volume":"37","author":[{"given":"Jonathan B.","family":"Carmichael","sequence":"first","affiliation":[{"name":"Eurofins NTD, LLC; Melville NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiao-Pin","family":"Liu","sequence":"additional","affiliation":[{"name":"Eurofins NTD, LLC; Melville NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Janik","sequence":"additional","affiliation":[{"name":"Eurofins NTD, LLC; Melville NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrence W.","family":"Hallahan","sequence":"additional","affiliation":[{"name":"Eurofins NTD, LLC; Melville NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kypros H.","family":"Nicolaides","sequence":"additional","affiliation":[{"name":"Harris Birthright Research Centre for Fetal Medicine; King's College Hospital; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2310-6003","authenticated-orcid":false,"given":"David A.","family":"Krantz","sequence":"additional","affiliation":[{"name":"Eurofins NTD, LLC; Melville NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,7,18]]},"reference":[{"key":"10.1002\/pd.5090-BIB0001|pd5090-cit-0002","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0002-9378(84)90530-1","article-title":"An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities","volume":"148","author":"Merkatz","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/pd.5090-BIB0002|pd5090-cit-0003","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/pd.1970070904","article-title":"Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities","volume":"7","author":"Bogart","year":"1987","journal-title":"Prenat Diagn"},{"key":"10.1002\/pd.5090-BIB0003|pd5090-cit-0004","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1471-0528.1988.tb06601.x","article-title":"Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome","volume":"95","author":"Canick","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1002\/pd.5090-BIB0004|pd5090-cit-0005","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0002-9378(90)90700-H","article-title":"Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin","volume":"163","author":"Macri","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/pd.5090-BIB0005|pd5090-cit-0006","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJM199605093341904","article-title":"Dimeric inhibin A as a marker for Down's syndrome in early pregnancy","volume":"334","author":"Aitken","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1002\/pd.5090-BIB0006|pd5090-cit-0007","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/pd.1211","article-title":"Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening","volume":"25","author":"Cicero","year":"2005","journal-title":"Prenat Diagn"},{"key":"10.1002\/pd.5090-BIB0007|pd5090-cit-0008","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/pd.2792","article-title":"First trimester Down syndrome screening with dried blood spots using a dual analyte free beta hCG and PAPP-A immunofluorometric assay","volume":"31","author":"Krantz","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1002\/pd.5090-BIB0008|pd5090-cit-0009","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/pd.4194","article-title":"First-trimester Down syndrome screening using additional serum markers with and without nuchal translucency and cell-free DNA","volume":"33","author":"Johnson","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1002\/pd.5090-BIB0009|pd5090-cit-0010","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/pd.4596","article-title":"Incorporation of dried blood alpha fetoprotein into traditional first trimester Down syndrome screening service","volume":"35","author":"Carmichael","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1002\/pd.5090-BIB0010|pd5090-cit-0011","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000330198","article-title":"First-trimester screening for trisomy 21 using alpha-fetoprotein","volume":"30","author":"Bredaki","year":"2011","journal-title":"Fetal Diagn Ther"},{"key":"10.1002\/pd.5090-BIB0011|pd5090-cit-0012","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/pd.4609","article-title":"Evaluating first trimester maternal serum screening combinations for Down syndrome suitable for use with reflexive secondary screening via sequencing of cell free DNA: high detection with low rates of invasive procedures","volume":"35","author":"Palomaki","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1002\/pd.5090-BIB0012|pd5090-cit-0013","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/pd.5090-BIB0013|pd5090-cit-0014","doi-asserted-by":"crossref","first-page":"205.e1","DOI":"10.1016\/j.ajog.2010.12.060","article-title":"Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting","volume":"204","author":"Ehrich","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/pd.5090-BIB0014|pd5090-cit-0015","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/GIM.0b013e3182368a0e","article-title":"DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study","volume":"13","author":"Palomaki","year":"2011","journal-title":"Genet Med"},{"key":"10.1002\/pd.5090-BIB0015|pd5090-cit-0016","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/AOG.0b013e31824fb482","article-title":"MatErnal BLood IS source to accurately diagnose fetal aneuploidy (MELISSA) study group. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing","volume":"119","author":"Bianchi","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1002\/pd.5090-BIB0016|pd5090-cit-0017","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/uog.14791","article-title":"Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis","volume":"45","author":"Gil","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1002\/pd.5090-BIB0017|pd5090-cit-0018","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/pd.4157","article-title":"Maternal cfDNA screening for Down syndrome - a cost sensitivity analysis","volume":"33","author":"Cuckle","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1002\/pd.5090-BIB0018|pd5090-cit-0019","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/pd.4311","article-title":"The price of performance: a cost and performance analysis of the implementation of cell-free fetal DNA testing for Down syndrome in Ontario, Canada","volume":"34","author":"Okun","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1002\/pd.5090-BIB0019|pd5090-cit-0020","doi-asserted-by":"crossref","first-page":"e93559","DOI":"10.1371\/journal.pone.0093559","article-title":"Model-based analysis of costs and outcomes of non-nnvasive prenatal testing for Down's syndrome using cell free fetal DNA in the UK National Health Service","volume":"9","author":"Morris","year":"2014","journal-title":"PLoS One"},{"key":"10.1002\/pd.5090-BIB0020|pd5090-cit-0021","doi-asserted-by":"crossref","first-page":"i3426","DOI":"10.1136\/bmj.i3426","article-title":"Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units","volume":"354","author":"Chitty","year":"2016","journal-title":"BMJ"},{"key":"10.1002\/pd.5090-BIB0021|pd5090-cit-0022","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ajh.2008.20","article-title":"Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004","volume":"21","author":"Wallis","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1002\/pd.5090-BIB0022|pd5090-cit-0023","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13\u00a0weeks gestation","volume":"214","author":"O'Gorman","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/pd.5090-BIB0023|pd5090-cit-0024","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/uog.14809","article-title":"Serum alpha-fetoprotein in the three trimesters of pregnancy: effects of maternal characteristics and medical history","volume":"46","author":"Bredaki","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1002\/pd.5090-BIB0024|pd5090-cit-0025","unstructured":"Carmichael JB Krantz DA Use of alpha-fetoprotein for detection of preeclampsia Alpha-Fetoprotein Functions and Clinical Applications Lakhi N Moretti M Novs Science Publishers Hauppauge 149 162"},{"key":"10.1002\/pd.5090-BIB0025|pd5090-cit-0026","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1002\/pd.5090-BIB0026|pd5090-cit-0027","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/pd.5090-BIB0027|pd5090-cit-0028","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/uog.14819","article-title":"Prediction and prevention of early-onset pre-eclampsia: Impact of aspirin after first-trimester screening","volume":"46","author":"Park","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1002\/pd.5090-BIB0028|pd5090-cit-0029","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1471-0528.1975.tb00710.x","article-title":"A critical evaluation of sonar crown rump length measurements","volume":"82","author":"Robinson","year":"1975","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1002\/pd.5090-BIB0029|pd5090-cit-0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/pd.2642","article-title":"Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13\u00a0weeks","volume":"31","author":"Syngelaki","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1002\/pd.5090-BIB0030|pd5090-cit-0031","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/pd.2637","article-title":"Screening for fetal aneuploidies at 11 to 13\u00a0weeks","volume":"31","author":"Nicolaides","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1002\/pd.5090-BIB0031|pd5090-cit-0032","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000357430","article-title":"First-trimester screening for trisomies 21, 18 and 13 by ultrasound and biochemical testing","volume":"35","author":"Wright","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"10.1002\/pd.5090-BIB0032|pd5090-cit-0033","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000338655","article-title":"Birthweight with gestation and maternal characteristics in live births and stillbirths","volume":"32","author":"Poon","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1002\/pd.5090-BIB0033|pd5090-cit-0034","first-page":"282","article-title":"Rates of chromosome abnormalities at different maternal ages","volume":"58","author":"Hook","year":"1981","journal-title":"Obstet Gynecol"},{"key":"10.1002\/pd.5090-BIB0034|pd5090-cit-0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1471-0528.1987.tb03115.x","article-title":"Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level","volume":"94","author":"Cuckle","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1002\/pd.5090-BIB0035|pd5090-cit-0036","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/(SICI)1097-0223(199702)17:2<155::AID-PD58>3.0.CO;2-1","article-title":"First-trimester growth patterns of aneuploid fetuses","volume":"17","author":"Schemmer","year":"1997","journal-title":"Prenat Diagn"},{"key":"10.1002\/pd.5090-BIB0036|pd5090-cit-0037","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/9781444314342.ch24","volume-title":"Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment","author":"Cuckle","year":"2010"},{"key":"10.1002\/pd.5090-BIB0037|pd5090-cit-0038","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/uog.992","article-title":"Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan","volume":"23","author":"Cicero","year":"2004","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1002\/pd.5090-BIB0038|pd5090-cit-0039","unstructured":"Centers for Disease Control and Prevention National Center for Health Statistics http:\/\/www.VitalStats.\/nchs\/vitalstats.htm 2014"},{"key":"10.1002\/pd.5090-BIB0039|pd5090-cit-0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/uog.12511","article-title":"First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing","volume":"42","author":"Nicolaides","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1002\/pd.5090-BIB0040|pd5090-cit-0041","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA analysis for noninvasive examination of trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1002\/pd.5090-BIB0041|pd5090-cit-0042","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/pd.4054","article-title":"Nearly a third of abnormalities found after first-trimester screening are different than expected: 10-year experience from a single center","volume":"33","author":"Alamillo","year":"2013","journal-title":"Prenat Diagn"},{"issue":"11","key":"10.1002\/pd.5090-BIB0042|pd5090-cit-0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7110","article-title":"First and second trimester antenatal screening for Down's syndrome: the results of the serum, urine and ultrasound screening study (SURUSS)","volume":"7","author":"Wald","year":"2003","journal-title":"Health Technol Assess"}],"container-title":["Prenatal Diagnosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpd.5090","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pd.5090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T19:37:00Z","timestamp":1719257820000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pd.5090"}},"subtitle":["Expanded conventional first trimester screening"],"short-title":[],"issued":{"date-parts":[[2017,7,18]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1002\/pd.5090","archive":["Portico"],"relation":{},"ISSN":["0197-3851"],"issn-type":[{"value":"0197-3851","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7,18]]}}}